June 19–21, 2014 | Seaport Hotel & World Trade Center | Boston, Massachusetts
The Cardiometabolic Syndrome is a construct of risk factors that increase the risk of developing cardiovascular disease. While there is some debate as to whether this is truly a syndrome with interconnecting pathophysiologic roots, the clinical implications are clear, transcend the academic debate, and are becoming increasingly crucial for clinicians to understand. These risk factors must be addressed early and effectively, as the clinical associations of these risk factors with multiple other important medical conditions are significant to both the health of many individuals and our ability to in address the national and international epidemic of the resulting cardiovascular disease as well.
For this reason, this program has been developed to take a high level look at the components of the cardiometabolic syndrome, its related clinical conditions, and clinical approaches to control them. It will combine discussions of cutting-edge basic and clinical science with the latest clinical care recommendations so each of these perspectives can be viewed in the context of the other. The presentations will be lectures where knowledge-based learning of the advances in science and treatments are the focus, and will use clinical case vignettes when emphasis of the clinical pull-through is the learning objective. The goal is for learners to appreciate the spectrum of clinical implications and presentations that his constellation of syndrome-like abnormalities can bring with it and improve their clinical skills in addressing them in a timely and effective manner.
Upon completion of this activity, participants will be able to:
- Name the markers of increased cardiometabolic risk, including components of cardiometabolic syndrome, biomarkers, and other key clinical factors
- Identify the components of the Cardiometabolic Syndrome in patients at increased risk
- Describe methods of diagnosing, preventing and treating the various clinical conditions related to or associated with increased cardiometabolic risk/syndrome.
- Select appropriate methods to manage weight so as to reduce the role of obesity in the etiology of cardiometabolic risk
- Choose specific preventative and treatment strategies for Cardiometabolic Risk in specific racial/ethnic minorities Assess one’s own practice to determine what Cardiometabolic risk factor interventions will be provided within the practice vs. what will be outsourced to area specialty resources
- Implement improvements in office-based process for screening and treating cardiometabolic risk
Page last updated: February 26, 2017